Clinically relevant concentrations of fosfomycin combined with polymyxin B, tobramycin or ciprofloxacin enhance bacterial killing of Pseudomonas aeruginosa, but do not suppress the emergence of fosfomycin resistance.
about
Synergistic combinations of polymyxins.The Potential Role of Fosfomycin in Neonatal Sepsis Caused by Multidrug-Resistant Bacteria.Fosfomycin: Mechanism and Resistance.Inhaled Antimicrobials for Ventilator-Associated Pneumonia: Practical Aspects.Validation of the mutant selection window hypothesis with fosfomycin against Escherichia coli and Pseudomonas aeruginosa: an in vitro and in vivo comparative study.Fosfomycin: Pharmacological, Clinical and Future Perspectives.Better living through chemistry: Addressing emerging antibiotic resistance.
P2860
Q37586960-883A18E2-AE43-49AF-8349-B823E4310F15Q38689344-4DA58F8A-198D-4793-AB5C-B68C2D49AF8BQ39071416-2240AD63-0A61-4882-8FCE-C53D1A37415CQ40121090-B694775D-AEF8-4B47-A36E-A55150B60D5FQ40499211-5F9548C4-C1DD-48FC-AEC6-9BDC1C7638ECQ47136072-6C37C20C-B60D-4426-9363-75B588DF01FCQ48096762-878F709A-B46B-48CB-86CB-AEAB57EB6FF2
P2860
Clinically relevant concentrations of fosfomycin combined with polymyxin B, tobramycin or ciprofloxacin enhance bacterial killing of Pseudomonas aeruginosa, but do not suppress the emergence of fosfomycin resistance.
description
2016 nî lūn-bûn
@nan
2016年の論文
@ja
2016年論文
@yue
2016年論文
@zh-hant
2016年論文
@zh-hk
2016年論文
@zh-mo
2016年論文
@zh-tw
2016年论文
@wuu
2016年论文
@zh
2016年论文
@zh-cn
name
Clinically relevant concentrat ...... ence of fosfomycin resistance.
@en
type
label
Clinically relevant concentrat ...... ence of fosfomycin resistance.
@en
prefLabel
Clinically relevant concentrat ...... ence of fosfomycin resistance.
@en
P2093
P2860
P50
P356
P1476
Clinically relevant concentrat ...... gence of fosfomycin resistance
@en
P2093
Clare C Walsh
Elizabeth B Hirsch
Phillip J Bergen
P2860
P304
P356
10.1093/JAC/DKW115
P407
P577
2016-04-26T00:00:00Z